Patient Leaflet Updated 10-May-2024 | AstraZeneca UK Limited
Lokelma 5 g & 10 g powder for oral suspension
Lokelma® 5 g powder for oral suspension
Lokelma® 10 g powder for oral suspension
sodium zirconium cyclosilicate
1. What Lokelma is and what it is used for
2. What you need to know before you take Lokelma
3. How to take Lokelma
4. Possible side effects
5. How to store Lokelma
6. Contents of the pack and other information
Lokelma contains the active substance sodium zirconium cyclosilicate.
Lokelma is used to treat hyperkalaemia in adults. Hyperkalaemia means that there is a high level of potassium in the blood.
Lokelma lowers the high levels of potassium in your body and helps to keep it at a normal level. As Lokelma passes through your stomach and gut it attaches to potassium and the two are carried together out of the body in your stools, lowering the amount of potassium in the body.
Monitoring
Your doctor or nurse will check your blood potassium level when you start taking this medicine:
While you are taking Lokelma, tell your doctor or nurse if
Do not give this medicine to children and adolescents under 18 years of age. This is because the effects of Lokelma in children and adolescents are not known.
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.
Lokelma may affect how certain medicines are absorbed from your digestive tract. If you are taking any of the following medicines, they should be taken 2 hours before or after taking Lokelma, otherwise they may not work properly.
If any of the above apply to you (or you are not sure), tell your doctor, pharmacist or nurse before taking this medicine.
Pregnancy
Do not use this medicine during pregnancy because there is no information on its use in pregnancy.
Breast-feeding
No effects on the breastfed newborn/infant are anticipated since the systemic exposure of the breast-feeding woman to Lokelma is negligible. Lokelma can be used during breast-feeding.
This medicine has no or negligible influence on your ability to drive or to use machines.
This medicine contains approximately 400 mg sodium (main component of cooking/table salt) in each 5 g dose. This is equivalent to 20% of the recommended maximum daily dietary intake of sodium for an adult.
Talk to your pharmacist or doctor if you need Lokelma 5 g or more daily for a prolonged period, especially if you have been advised to follow a low salt (sodium) diet.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Starting dose - to lower your high potassium level to normal:
Maintenance dose - to keep your potassium level within the normal range after it has been lowered:
If you are on haemodialysis therapy:
If you take more Lokelma than you should:
If you take more of this medicine than you should, talk to a doctor straight away. Do not take any more until you have spoken to a doctor.
If you forget to take Lokelma
If you stop taking Lokelma
Do not reduce the dose of this medicine or stop taking it without talking to the doctor who prescribed it. This is because you may get high potassium levels in your blood again.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor or nurse if you experience any of the following:
Common side effects (may affect up to 1 in 10 people).
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the sachet after ‘EXP’. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is sodium zirconium cyclosilicate.
Lokelma 5 g powder for oral suspension
Each sachet contains 5 g of sodium zirconium cyclosilicate.
Lokelma 10 g powder for oral suspension
Each sachet contains 10 g of sodium zirconium cyclosilicate.
There are no other ingredients in this medicine.
The powder for oral suspension is a white to grey powder. It comes in a sachet.
Lokelma 5 g powder for oral suspension
Each sachet contains 5 g of powder.
Lokelma 10 g powder for oral suspension
Each sachet contains 10 g of powder.
The sachets are supplied in a carton containing 3 or 30 sachets.
Not all pack sizes may be marketed.
This leaflet was last revised in 03/2024
© AstraZeneca 2024
Lokelma is a registered trademark of the AstraZeneca group of companies.
CV 24 0023
Other sources of information
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name Reference number
Lokelma 5 g powder for oral suspension 17901/0332
Lokelma 10 g powder for oral suspension 17901/0331
This is a service provided by the Royal National Institute of the Blind.
2 Pancras Square, 8th Floor, London, N1C 4AG, UK
+44 (0)1582 838 000
www.myazmed.co.uk
+44 (0)1582 836 000
0800 783 0033
https://medicalinformation.astrazeneca.co.uk/